Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '(S)-MEPHENYTOIN 4''-HYDROXYLASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gerbal-Chaloin, S; Pascussi, JM; Pichard-Garcia, L; Daujat, M; Waechter, F; Fabre, JM; Carrere, N; Maurel, P
      Induction of CYP2C genes in human hepatocytes in primary culture

      DRUG METABOLISM AND DISPOSITION
    2. Ha-Duong, NT; Dijols, S; Macherey, AC; Goldstein, JA; Dansette, PM; Mansuy, D
      Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P4502C19

      BIOCHEMISTRY
    3. Shu, Y; Zhou, HH
      Individual and ethnic differences in CYP2C19 activity in Chinese populations

      ACTA PHARMACOLOGICA SINICA
    4. Qin, YP; Xie, HG; Wang, W; He, N; Huang, SL; Xu, ZH; Ou-Yang, DS; Wang, YJ; Zhou, HH
      Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    5. Smith, G; Stubbins, MJ; Harries, LW; Wolf, CR
      Molecular genetics of the human cytochrome P450 monooxygenase superfamily

      XENOBIOTICA
    6. LUO G; ZELDIN DC; BLAISDELL JA; HODGSON E; GOLDSTEIN JA
      CLONING AND EXPRESSION OF MURINE CYP2CS AND THEIR ABILITY TO METABOLIZE ARACHIDONIC-ACID

      Archives of biochemistry and biophysics (Print)
    7. TRELUYER JM; GUERET G; CHERON G; SONNIER M; CRESTEIL T
      DEVELOPMENTAL EXPRESSION OF CYP2C AND CYP2C-DEPENDENT ACTIVITIES IN THE HUMAN LIVER - IN-VIVO IN-VITRO CORRELATION AND INDUCIBILITY/

      Pharmacogenetics
    8. NASU K; KUBOTA T; ISHIZAKI T
      GENETIC-ANALYSIS OF CYP2C9 POLYMORPHISM IN A JAPANESE POPULATION

      Pharmacogenetics
    9. CHANG TKH; YU L; GOLDSTEIN JA; WAXMAN DJ
      IDENTIFICATION OF THE POLYMORPHICALLY EXPRESSED CYP2C19 AND THE WILD-TYPE CYP2C9-ILE359 ALLELE AS LOW-K-M CATALYSTS OF CYCLOPHOSPHAMIDE ANDIFOSFAMIDE ACTIVATION

      Pharmacogenetics
    10. BHASKER CR; MINERS JO; COULTER S; BIRKETT DJ
      ALLELIC AND FUNCTIONAL VARIABILITY OF CYTOCHROME P4502C9

      Pharmacogenetics
    11. BHASKER CR; MINERS JO; COULTER S; BIRKETT DJ
      ALLELIC AND FUNCTIONAL VARIABILITY OF CYTOCHROME P4502C9

      Pharmacogenetics
    12. ZHANG ZY; KERR J; WEXLER RS; LI HY; ROBINSON AJ; HARLOW PP; KAMINSKY LS
      WARFARIN ANALOG INHIBITION OF HUMAN CYP2C9-CATALYZED S-WARFARIN 7-HYDROXYLATION

      Thrombosis research
    13. STUBBINS MJ; HARRIES LW; SMITH G; TARBIT MH; WOLF CR
      GENETIC-ANALYSIS OF THE HUMAN CYTOCHROME-P450 CYP2C9 LOCUS

      Pharmacogenetics
    14. SULLIVANKLOSE TH; GHANAYEM BI; BELL DA; ZHANG ZY; KAMINSKY LS; SHENFIELD GM; MINERS JO; BIRKETT DJ; GOLDSTEIN JA
      THE ROLE OF THE CYP2C9-LEU(359) ALLELIC VARIANT IN THE TOLBUTAMIDE POLYMORPHISM

      Pharmacogenetics
    15. XU ZH; XIE HG; ZHOU HH
      IN-VIVO INHIBITION OF CYP2C19 BUT NOT CYP2D6 BY FLUVOXAMINE

      British journal of clinical pharmacology
    16. MAUREL P
      THE USE OF ADULT HUMAN HEPATOCYTES IN PRIMARY CULTURE AND OTHER IN-VITRO SYSTEMS TO INVESTIGATE DRUG-METABOLISM IN MAN

      Advanced drug delivery reviews
    17. JEAN P; LOPEZGARCIA P; DANSETTE P; MANSUY D; GOLDSTEIN JL
      OXIDATION OF TIENILIC ACID BY HUMAN YEAST-EXPRESSED CYTOCHROMES P-4502C8, 2C9, 2C18 AND 2C19 - EVIDENCE THAT THIS DRUG IS A MECHANISM-BASED INHIBITOR SPECIFIC FOR CYTOCHROME-P-450 2C9

      European journal of biochemistry
    18. MANCY A; DIJOLS S; POLI S; GUENGERICH FP; MANSUY D
      INTERACTION OF SULFAPHENAZOLE DERIVATIVES WITH HUMAN LIVER CYTOCHROMES P450 2C - MOLECULAR-ORIGIN OF THE SPECIFIC INHIBITORY EFFECTS OF SULFAPHENAZOLE ON CYP 2C9 AND CONSEQUENCES FOR THE SUBSTRATE-BINDING SITETOPOLOGY OF CYP 2C9

      Biochemistry
    19. HAINING RL; HUNTER AP; VERONESE ME; TRAGER WF; RETTIE AE
      ALLELIC VARIANTS OF HUMAN CYTOCHROME-P450 2C9 - BACULOVIRUS-MEDIATED EXPRESSION, PURIFICATION, STRUCTURAL CHARACTERIZATION, SUBSTRATE STEREOSELECTIVITY, AND PROCHIRAL SELECTIVITY OF THE WILD-TYPE AND I359L MUTANT FORMS

      Archives of biochemistry and biophysics
    20. KOBAYASHI K; YAMAMOTO T; CHIBA K; TANI M; ISHIZAKI T; KUROIWA Y
      THE EFFECTS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND THEIR METABOLITES ON S-MEPHENYTOIN 4'-HYDROXYLASE ACTIVITY IN HUMAN LIVER-MICROSOMES

      British journal of clinical pharmacology
    21. SETIABUDY R; KUSAKA M; CHIBA K; DARMANSJAH I; ISHIZAKI T
      METABOLIC DISPOSITION OF PROGUANIL IN EXTENSIVE AND POOR METABOLIZERSOF S-MEPHENYTOIN 4'-HYDROXYLATION RECRUITED FROM AN INDONESIAN POPULATION

      British journal of clinical pharmacology
    22. CHIBA K; SAITOH A; KOYAMA E; TANI M; HAYASHI M; ISHIZAKI T
      THE ROLE OF S-MEPHENYTOIN 4'-HYDROXYLASE IN IMIPRAMINE METABOLISM BY HUMAN LIVER-MICROSOMES - A 2-ENZYME KINETIC-ANALYSIS OF N-DEMETHYLATION AND 2-HYDROXYLATION

      British journal of clinical pharmacology
    23. CHIBA K; MANABE K; KOBAYASHI K; TAKAYAMA Y; TANI M; ISHIZAKI T
      DEVELOPMENT AND PRELIMINARY APPLICATION OF A SIMPLE ASSAY OF S-MEPHENYTOIN 4-HYDROXYLASE ACTIVITY IN HUMAN LIVER-MICROSOMES

      European Journal of Clinical Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 21:34:24